Boots sells Nurofen business

Boots unveiled its second major deal of the week today after raising £1.93bn (€2.8bn) from the sale of its business making Nurofen and Strepsils.

Reckitt Benckiser, the company behind consumer and household products such as Lemsip and Harpic, beat strong competition to win the auction, which raised more than market analysts had been expecting.